We are live on ! Find out more
VRCA icon

Verrica Pharmaceuticals
VRCA

34 hedge funds and large institutions have $10.6M invested in Verrica Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

23.45% more ownership

Funds ownership: 2.69% → 26.15% (+23%)

21% less capital invested

Capital invested by funds: $13.4M → $10.6M (-$2.86M)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

41% less funds holding

Funds holding: 58 → 34 (-24)

80% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 30

Holders
34
Holders Change
-24
Holders Change %
-41.38%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
16
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFM
Boothbay Fund Management
New York
+$1.69M
2
UBS Group
UBS Group
Switzerland
+$207K
3
Renaissance Technologies
Renaissance Technologies
New York
+$123K
4
Morgan Stanley
Morgan Stanley
New York
+$115K
5
BCM
Bridgeway Capital Management
Texas
+$72.4K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.5M
2
Millennium Management
Millennium Management
New York
-$113K
3
YIH
Y-Intercept (HK)
Hong Kong
-$99.1K
4
Goldman Sachs
Goldman Sachs
New York
-$92.9K
5
BCM
BML Capital Management
Indiana
-$92.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
51
Cambridge Investment Research Advisors
Iowa
– -$6K -1,150 Closed
XT
52
XTX Topco
Cayman Islands
– -$5.86K -1,106 Closed
KFI
53
Key Financial Inc
Pennsylvania
– -$4.99K -942 Closed
Raymond James Financial
54
Raymond James Financial
Florida
– -$4.45K -840 Closed
LT
55
Legacy Trust
Michigan
– -$3.45K -650 Closed
Wells Fargo
56
Wells Fargo
California
– -$2.61K -493 Closed
Carson Wealth (CWM LLC)
57
Carson Wealth (CWM LLC)
Nebraska
– -$1.84K -306 -85%
CSS
58
Cubist Systematic Strategies
Connecticut
– -$1.04K -196 Closed
AAS
59
Ameritas Advisory Services
Nebraska
– -$159 -30 Closed
Jones Financial Companies
60
Jones Financial Companies
Missouri
– -$38 -7 Closed
EWA
61
EverSource Wealth Advisors
Alabama
– -$26 -5 Closed
EP
62
Essential Partners
California
– -$8 -2 Closed
C
63
Covestor
United Kingdom
– -$6 -1 -2%
IA
64
IFP Advisors
Florida
– -$3 -1 Closed
SS
65
SBI Securities
Japan
– -$1 – –
1 2
3

VRCA Hedge Fund Activity: Q3 2025 in Review

34 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Verrica Pharmaceuticals (VRCA) for Q3 2025, worth a combined $10.6M — down 21% from $13.4M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of VRCA and 6 opened new positions — a net loss of 24 holders — while 16 trimmed existing stakes and 11 added.

The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $1.69M. The largest seller was Armistice Capital, cutting an estimated $1.5M.

  • 34 institutional investors held Verrica Pharmaceuticals (VRCA) as of Q3 2025, down from 58 in Q2 2025.
  • Funds reported $10.6M of Verrica Pharmaceuticals stock for Q3 2025, down 21% quarter-over-quarter.
  • 6 funds opened new Verrica Pharmaceuticals positions in Q3 2025 and 30 closed out, a net change of -24 holders.
  • The largest Verrica Pharmaceuticals buyer in Q3 2025 was Boothbay Fund Management, an estimated $1.69M added.
  • The largest Verrica Pharmaceuticals seller in Q3 2025 was Armistice Capital, an estimated $1.5M sold.

Based on aggregated 13F filings for Q3 2025.